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SUPPLEMENT

Procedural and Physical Interventions for Vaccine Injections
Systematic Review of Randomized Controlled Trials and
Quasi-Randomized Controlled Trials
Anna Taddio, BScPhm, MSc, PhD,*w Vibhuti Shah, MD, MSc,zy
C. Meghan McMurtry, PhD, C Psych,8z# Noni E. MacDonald, MD,**
Moshe Ipp, MD,yww Rebecca Pillai Riddell, PhD, C Psych,wzz Melanie Noel, PhD,yy
Christine T. Chambers, PhD, R Psych,88
and HELPinKids&Adults Team

Background: This systematic review evaluated the eﬀectiveness of
physical and procedural interventions for reducing pain and related
outcomes during vaccination.
Design/Methods: Databases were searched using a broad search
strategy to identify relevant randomized and quasi-randomized
controlled trials. Data were extracted according to procedure phase
(preprocedure, acute, recovery, and combinations of these) and
pooled using established methods.
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Results: A total of 31 studies were included. Acute infant distress
was diminished during intramuscular injection without aspiration
(n = 313): standardized mean diﬀerence (SMD)  0.82 (95% conﬁdence interval [CI]: 1.18, 0.46). Injecting the most painful vaccine
last during vaccinations reduced acute infant distress (n = 196): SMD
 0.69 (95% CI: 0.98,  0.4). Simultaneous injections reduced acute
infant distress compared with sequential injections (n = 172): SMD
 0.56 (95% CI:  0.87,  0.25). There was no beneﬁt of simultaneous
injections in children. Less infant distress during the acute and recovery
phases combined occurred with vastus lateralis (vs. deltoid) injections
(n = 185): SMD  0.70 (95% CI: 1.00,  0.41). Skin-to-skin contact
in neonates (n = 736) reduced acute distress: SMD 0.65 (95% CI:
 1.05,  0.25). Holding infants reduced acute distress after removal of
the data from 1 methodologically diverse study (n = 107): SMD
 1.25 (95% CI:  2.05,  0.46). Holding after vaccination (n = 417)
reduced infant distress during the acute and recovery phases combined:
SMD 0.65 (95% CI: 1.08,  0.22). Self-reported fear was reduced
for children positioned upright (n = 107): SMD 0.39 (95% CI:
 0.77,  0.01). Non-nutritive sucking (n = 186) reduced acute distress
in infants: SMD  1.88 (95% CI:  2.57,  1.18). Manual tactile
stimulation did not reduce pain across the lifespan. An external
vibrating device and cold reduced pain in children (n = 145): SMD
 1.23 (95% CI:  1.58,  0.87). There was no beneﬁt of warming the
vaccine in adults. Muscle tension was beneﬁcial in selected indices of
fainting in adolescents and adults.
Conclusions: Interventions with evidence of beneﬁt in select populations include: no aspiration, injecting most painful vaccine last,
simultaneous injections, vastus lateralis injection, positioning
interventions, non-nutritive sucking, external vibrating device with
cold, and muscle tension.
Key Words: pain management, randomized controlled trial, systematic review, vaccination, injection techniques

(Clin J Pain 2015;31:S20–S37)

V

accine injections are the most frequent painful medical
procedure performed worldwide. Numerous interventions have been evaluated to combat the pain from
vaccine injections.1 These interventions can be broadly
divided into pharmacological, psychological, procedural,
and physical approaches. But for the costs of training
clinicians, the majority of procedural and physical interventions oﬀer the advantage of being time and resource cost
neutral when compared with other approaches, and hence
can be applied across clinical settings.
In a previous knowledge synthesis on this topic, we
found support for several diﬀerent procedural and physical
Clin J Pain
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interventions.2 These interventions were subsequently incorporated in a clinical practice guideline about childhood vaccination pain management.1 Since the original guideline was
developed, additional research has been undertaken that has
the potential to impact previous conclusions. In addition, the
original guideline excluded research in adults, leaving a gap in
best practices for this population. The current systematic
review was therefore undertaken to update and expand the
knowledge synthesis on this topic.3
This manuscript reports the results for the eﬀects of
the following procedural and physical interventions: (1)
aspiration during intramuscular (IM) vaccine injection, (2)
order of injection for sequential vaccine injections, (3)
simultaneous versus sequential injection of multiple vaccines, (4) positioning of the individual undergoing vaccination, (5) anatomic location for the vaccine injection, (6)
non-nutritive sucking during vaccination, (7) tactile stimulation (manual and vibration) during vaccination, (8)
warming the vaccine, and (9) muscle tension (for individuals with a history of fainting). Breastfeeding, which combines physical (positioning and non-nutritive sucking) and
pharmacological (sweet-tasting substances) elements, is
included in a separate manuscript in this series.4 Similarly,
we also separately report on the eﬀects of combined interventions that include physical interventions (eg, nonnutritive sucking and sweet-tasting substances together)

Physical And Procedural Vaccination Pain Strategies

and the eﬀectiveness of muscle tension in individuals with
high levels of needle fear and a history of fainting.4,5

METHODS
A universal approach was used to carry out several
systematic reviews on the same topic; the methodological
details are provided elsewhere.3 Brieﬂy, both the Grading of
Assessments, Recommendations, Development and Evaluation (GRADE)6 and Cochrane7 methodologies guided the
review. The search strategy was developed with the assistance of an academic librarian and was executed in
EMBASE, Medline, PsycINFO, CINAHL, and ProQuest
Dissertations & Theses Global. Relevant citations were
screened and included as previously described.3
The review included individuals of all ages undergoing
vaccination in any setting or if not undergoing vaccination,
the closest related skin-breaking procedure or context (eg,
venipuncture) and randomized or quasi-randomized study
designs. We included studies published as a full report or
short report and published academic theses. The included
interventions, critical outcomes, and important outcomes
included in the review were identiﬁed from a national multidisciplinary team, Help ELiminate Pain in Kids & Adults
(HELPinKids&Adults), originally assembled for the speciﬁc
purpose of undertaking knowledge translation activities in

TABLE 1. Clinical Questions and Outcomes

Clinical Question
Procedural interventions
Should no aspiration be used (rather than aspiration) during
intramuscular vaccine injections in individuals of all ages?
Should injecting the most painful vaccine last be used (rather
than ﬁrst) during vaccine injections in individuals of all ages?
Should simultaneous injections be used (rather than sequential
injections) during vaccine injections in infants 0-1 y?
Should simultaneous injections be used (rather than sequential
injections) during vaccine injections in children above 1-10 y?
Should the vastus lateralis be used (rather than the deltoid) as
the site of injection during vaccine injections in infants 011 mo?
Physical interventions
Should skin-to-skin contact be used during vaccine injections in
neonates 0-1 mo?
Should holding be used (rather than lying supine) during vaccine
injections in children 0-3 y?
If holding is not used during vaccine injections, should a
combined holding intervention (including patting and/or
rocking) be used after vaccine injections in children 0-3 y?
Should sitting upright be used (rather than lying supine) during
vaccine injections in children above 3 y and adults?
Should non-nutritive sucking (using a ﬁnger/thumb, paciﬁer) be
used during vaccine injections in children 0-2 y?
Should manual tactile stimulation be used during vaccine
injections in individuals of all ages?
Should tactile stimulation using an external vibrating device and
cold be used during vaccine injections in children above 3-17 y?
Should warming the vaccine before vaccine injections be used in
individuals of all ages?
Should muscle tension be used for vaccine injections in children
7 y and above and adults with a history of fainting?

Critical
Outcomes*
Pain, distress
Pain, distress
Distress
Pain, distress
Distress

Distress
Distress
Distress
Pain, fear
Distress
Pain, distress
Pain, fear
Pain, distress
Fainting

Important Outcomes
Procedure outcome, compliance, satisfaction,
preference
Procedure outcome, compliance, satisfaction,
preference
Procedure outcome, parent fear, compliance,
preference, satisfaction
Fear, procedure outcome, parent fear, compliance,
memory, preference, satisfaction
Procedure outcome, safety, compliance, preference,
satisfaction

Procedure outcome, parent fear, use of intervention,
compliance, preference, satisfaction
Procedure outcome, parent fear, use of intervention,
compliance, preference, satisfaction
Procedure outcome, parent fear, use of intervention,
compliance, preference, satisfaction
Distress, procedure outcome, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Procedure outcome, parent fear, use of intervention,
compliance, preference, satisfaction
Fear, procedure outcome, use of intervention,
compliance, preference, satisfaction
Distress, procedure outcome, use of intervention,
compliance, preference, satisfaction
Preference, satisfaction
Pain, distress, fear, procedure outcome, compliance,
memory, preference, satisfaction

*Distress is the critical outcome in the absence of data for pain and/or fear in individuals incapable of self-report (eg, infants).
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this therapeutic area.3 Outcomes that were identiﬁed as critically important and important to decision making were
extracted, as available in included studies. Pain was typically
prioritized as the critically important outcome, deﬁned as
self-report of pain during vaccination. Distress was accepted
as the critically important outcome in patient populations for
which self-report was not possible (eg, infants) and was
additionally considered in populations for which self-report
could be unreliable (eg, children below 7 y). Distress was
deﬁned as observer-rated behavior of an individual’s response
during vaccination. Additional critical outcomes included
fear and fainting, depending on the intervention under evaluation.3 A list of included clinical questions and critically
important and important outcomes is shown in Table 1.
The Cochrane risk of bias tool (https://bmg.cochrane.
org/assessing-risk-bias-included-studies) was used to evaluate
methodological limitations and the RevMan software program (version 5.2, Cochrane Collaboration, Copenhagen,
Denmark) was used to pool the data. The eﬀect of each
intervention was expressed as a standardized mean diﬀerence
(SMD) with accompanying 95% conﬁdence interval (CI) or
relative risk (RR) and CI, as appropriate. A random eﬀects
model was used for all analyses. Statistical heterogeneity was
assessed using I2 and w2 tests.3
As previously reported,3 to more precisely describe the
eﬀects of the intervention, outcomes that were evaluated at
multiple time-points were analyzed according to the procedure phase: (1) the preprocedure phase, which occurred
postintervention but before vaccine injection(s); (2) the
acute procedure phase (within the ﬁrst minute of needle
puncture and vaccine injection); and (3) the recovery procedure phase (1 to 5 min after vaccine injection(s)). Late
onset pain at the injection site (ie, pain occurring hours to
days after injection), was not examined.
Data from multiple observers assessing the same outcome (eg, parent-rated child distress, clinician-rated child
distress) and data from multiple time-points within the
same procedure phase (eg, acute distress measured every
15 s within the ﬁrst minute of vaccine injection) were pooled
before inclusion in the meta-analysis using established
methods.8 An emphasis was placed on the eﬀects of an
intervention during the acute procedure phase.
Means and SDs were calculated from medians, ranges,
SEs, and 95% CI or estimated from graphs. Authors of
trials were contacted for further details and provision of
original data if the published report contained insuﬃcient
information. Modiﬁcation of original data was done (eg,
range conversion to SD) on a very restricted predeﬁned
basis, as needed, according to established methods.9
Separate analyses were conducted to account for developmental stage, attributes of the intervention, or both. For
simultaneous injections, infants were analyzed separately from
children. For positioning interventions, the eﬀects of skin-toskin contact were analyzed in neonates while holding was
analyzed in infants and sitting upright was analyzed in children. Holding interventions applied postvaccination were
analyzed separately from holding during vaccination. Finally,
tactile stimulation was analyzed according to whether it was
delivered manually or with an external vibrating device.
Analyses are presented according to these a priori decisions. In
addition, analyses were carried out to examine the eﬀects of
including and excluding studies of low study methodology
and/or to examine heterogeneity.
Evidence proﬁles and summary of ﬁndings tables were
created using the GRADE proﬁler software (version 3.6.1) in

S22 | www.clinicalpain.com
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which all judgments pertaining to evaluation of quality of
evidence were recorded. When ﬁndings demonstrated a beneﬁt across critical outcomes, the intervention was said to have
beneﬁt across all measured outcomes. When the results were
inconsistent across all measured outcomes, the results were
said to be “mixed.” Interventions without statistical evidence
of beneﬁt were said to have no evidence of a beneﬁt.

RESULTS
A total of 114,251 citations were retrieved from the
databases. Another 138 were identiﬁed separately from
manual searches of various sources (eg, reference lists). All
citations were saved in an EndNote library that identiﬁed
32,155 duplicates. The remaining 82,234 citations were
reviewed by 2 of the authors (A.T., V.S.) against the
inclusion criteria.3 Thirty-seven studies investigating procedural and physical interventions were included in the
review.10–46 In 6 cases, multiple citations were identiﬁed for
the same study; 3 of them included a dissertation41–43 and
published manuscript of the same data,20,30,33 and the other
3 included multiple citations44–46 to the same study.27 The
proﬁle summarizing the trial ﬂow is shown in Figure 1.
Characteristics of included trials are displayed in Table 2.
Excluded studies included: (1) combined interventions versus
control (n = 1)47; (2) head-to-head comparisons (n = 2)48,49;
(3) studies that did not include interventions according to the
clinical question (n = 2)50,51; and (4) studies with insuﬃcient
data (n = 2).52,53 Altogether, 28 studies utilized a betweengroups (parallel) design; the remaining 3 used a cross-over
design. In 1 cross-over study,11 only the results from the ﬁrst
day were included; hence, mimicking a between-groups design.
All studies provided data for 2 or more treatment arms. Four
studies included adults, 24 included children, and 3 included
both adults and children.

Quality of Studies and Risk of Bias
Table 3 shows the results for the risk of bias assessment
for critical outcomes. All trials had a high overall risk of bias
primarily due to lack of blinding of important personnel.

Overall Quality of Evidence and Treatment
Effects
A quantitative summary of the treatment eﬀects for
available critical outcomes is provided below, according to
the clinical question; a qualitative summary is displayed
in Table 4. Supporting GRADE Evidence Proﬁles and
Summary of Findings tables (see Tables, Supplemental
Digital Content 1 to 14, http://links.lww.com/CJP/A282,
http://links.lww.com/CJP/A283, http://links.lww.com/CJP/
A284, http://links.lww.com/CJP/A285, http://links.lww.
com/CJP/A286, http://links.lww.com/CJP/A287, http://
links.lww.com/CJP/A288, http://links.lww.com/CJP/A289,
http://links.lww.com/CJP/A290, http://links.lww.com/CJP/
A291, http://links.lww.com/CJP/A292, http://links.lww.com/
CJP/A293, http://links.lww.com/CJP/A294, http://links.lww.
com/CJP/A295) and accompanying Forest plots (see Figures,
Supplemental Digital Content 1-14, http://links.lww.com/
CJP/A296, http://links.lww.com/CJP/A297, http://links.lww.
com/CJP/A298, http://links.lww.com/CJP/A299, http://links.
lww.com/CJP/A300, http://links.lww.com/CJP/A301, http://
links.lww.com/CJP/A302, http://links.lww.com/CJP/A303,
http://links.lww.com/CJP/A304, http://links.lww.com/CJP/
A305, http://links.lww.com/CJP/A306, http://links.lww.com/
CJP/A307, http://links.lww.com/CJP/A308, http://links.lww.
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Identification

Records identified through
database searching
(n = 114251)

Additional records identified
through other sources
(n = 138)

Total records retrieved
(n = 114389)

Screening

Duplicate references
(n = 32155)

Screened for eligibility
(n = 82234)

Full-text articles excluded
due to head-to-head
comparison, combined
intervention, intervention
differs from clinical
question, inadequate
reporting of study details
(n = 7)

Included

The remainder was not
relevant/outside of scope

Studies included in
systematic review
(n = 31)

Duplicate data
(n = 6)

FIGURE 1. Flow of studies.

com/CJP/A309) for critically important and important outcomes are included as Supplemental Digital Content.

Should No Aspiration be Used (Rather Than
Aspiration) During IM Injections in Individuals of
All Ages?
Three trials including infants, children, and adults
investigated the eﬀects of not aspirating before IM vaccine
injections.10–12 There was very low quality of evidence and
the results were mixed (see Table, http://links.lww.com/
CJP/A282 and Figure, http://links.lww.com/CJP/A296
SDC 1). In one of the studies including 114 children and
adults, there was no evidence of a beneﬁt for individuals
vaccinated in the absence of aspiration versus those vaccinated with aspiration: SMD 0.28 (95% CI: 0.12, 0.68). In
the other 2 studies including 313 infants, however, levels of
acute distress were lower in those who received fast injections without aspiration compared with those who received
slow injections with aspiration: SMD 0.82 (95% CI:
1.18, 0.46). Either a beneﬁt or no diﬀerence was
observed for other indicators of distress. It was not clear
whether diﬀerences between groups were obscured in the
former analysis by an insuﬃcient duration of time allocated
for aspiration, variability in the anatomic injection site, or
Copyright

r

the speciﬁc vaccine being administered to the participants.
Injection speed was a potential confounder in the latter
analysis.

Should Injecting the Most Painful Vaccine Last be
Used (Rather Than First) During Vaccine Injections in
Individuals of All Ages?
Two trials including infants in the ﬁrst 6 months of life
investigated the eﬀect of injecting the most painful vaccine
last.13,14 Included studies compared either: (1) pneumococcus conjugate vaccine, PCV (Prevnar) to diphtheria and
tetanus toxoids, polio, acellular pertussis, and Haemophilus
inﬂuenzae type b conjugate vaccine, DPTaP-Hib (Pentacel),
or (2) Bacille Calmette-Guérin vaccine, BCG (Tubervac) to
hepatitis B vaccine (GeneVac-B). There was moderate
quality evidence for distress, the critical outcome (see
Table, http://links.lww.com/CJP/A283 SDC 2). When
given ﬁrst, PCV and hepatitis B caused more pain than
DPTaP-Hib and BCG, respectively. Administering the
most painful vaccine last (ie, PCV after DPTaP-Hib and
hepatitis B after BCG, respectively) caused lower overall
infant acute distress for both injections (n = 196): SMD
0.69 (95% CI: 0.98,  0.40) (see Table http://

2015 Wolters Kluwer Health, Inc. All rights reserved.
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TABLE 2. Characteristics of the Trials Included in the Systematic Review

Author, Year,
Country

Injection Details

Population, Enrolled,
Design, Setting

Intervention, Sample
Size*

Critical Outcomes

Procedural interventions
Should no aspiration be used (rather than aspiration) during intramuscular vaccine injections in individuals of all ages?
DTwP 0.5 mL IM;
N = 200; children 6 wkRapid injection without
Distress: MBPS, cry
Girish & Ravi
24-G, 1-inch needle;
18 mo; betweenaspiration (n = 100)
2014,11 India
90-degree angle;
groups design; single
or
anterolateral thigh
center, hospital
Slow injection with
aspiration (n = 100)
Ipp et al 2007,10
DPTaP-Hib 0.5 mL IM;
N = 113; infants 4Rapid injection (1-2 s)
Distress: MBPS, VAS,
Canada
25-G, 22-mm needle;
6 mo; between-groups
without aspiration
cry
90-degree angle;
design; single center,
(n = 56)
anterolateral thigh
primary care practice
or
Slow injection (5-10 s)
with aspiration
(n = 57)
HPV (Gardasil); 23-G,
N = 114; women 14Petousis-Harris
Rapid injection without
Pain: VAS
25-mm needle; 9045 y and men 14-26 y;
et al 2013 (1,2),12
aspiration (< 1 s)
New Zealand
degree angle; deltoid
cross-over design;w
(n = 34)
clinics at the School of
or
Population Health
Slow without aspiration
(5-10 s) (n = 45)
or
Slow with
aspiration
(5-10 s)
(n = 35)
Should injecting the most painful vaccine last be used (rather than ﬁrst) during vaccine injections in individuals of all ages?
DPTaP-Hib (Pentacel),
N = 120; infants 2DPTaP-Hib (Pentacel)
Distress: MBPS, VAS,
Ipp et al 2009,13
Canada
PCV (Prevnar);
6 mo; between-groups
ﬁrst, then PCV
cry
0.5 mL/vaccine IM;
design; single center,
(Prevnar) (n = 60)
25-G, 22-mm needle;
primary care practice
or
90-degree angle;
PCV ﬁrst, then DPTaPanterolateral thigh,
Hib (n = 60)
1-2 s; alternate limbs
for each injection
Hepatitis B 0.5 mL IM;
N = 76; newborns;
BCG (Tubervac) ﬁrst,
Ravikiran et al
Distress: NIPS, VAS
14
23-G, 25-mm needle;
between-groups
then Hepatitis B
2011, India
anterolateral thigh;
design; single center,
(GeneVac-B) (n = 38)
BCG 0.1 mL ID; 26hospital vaccination
or
G, 13-mm needle; left
room
Hepatitis B ﬁrst, then
shoulder
BCG (n = 38)
Should simultaneous injections be used (rather than sequential injections) during vaccine injections in infants 0-1 y?
DPTP-Hib, Hepatitis B,
N = 101; infants 4 mo;
Simultaneous injection:
Distress: NIPS
Hanson et al
PCV; no injection
between-groups
ﬁrst 2 vaccines given
2010,15 Canada
details
design; multicenter,
simultaneously then
community health
third given up to 15 s
clinics
later (n = 49)
or
Sequential injection: all
3 vaccines given
sequentially with up
to 15 s between each
injection (n = 50)
DTaP-IPV-Hib + PCV
N = 73; infants 2-6 mo;
Simultaneous injection: 2
McGowan et al
Distress: MBPS, VAS
or DTaP-IPVbetween-groups
injections were given
2013,16 UK
Hib + MenC; IM;
design; single center,
and could be either
23-G 25-mm needle;
primary care practice
DTaP/IPV/Hib and
90-degree angle;
PCV or DTaP/IPV/Hib
anterolateral thigh,
and MenC (n = 37)
1-2 s no aspiration;
or
DTaP-IPV-Hib in
Sequential injection: 2
right thigh
injections were given
and could be either
DTaP/IPV/Hib and
PCV or DTaP/IPV/Hib
and MenC (n = 36)
(Continued )
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TABLE 2. (continued)
Author, Year,
Country

Injection Details

Population, Enrolled,
Design, Setting

Should simultaneous injections be used (rather than sequential injections) during
DPT and MMR; no
N = 46; children 4-6 y;
Horn and
injection details
between-groups
McCarthy 1999,17
USA
design; single center,
primary care practice

Intervention, Sample
Size*

Critical Outcomes

vaccine injections in children above 1-10 y?
Simultaneous injection
Pain: Wong-Baker
(n = 24)
FACES scale
or
Sequential injection
(n = 22)

Should the vastus lateralis be used (rather than the deltoid) as the site of injection during vaccine injections in infants 0-11 mo?
DTP 0.5 mL IM; 24- or
N = 185; infants 4 mo;
Vastus lateralis IM
Celebioglu et al
Distress: NIPS, cry
25-G needle; 90between-groups
injection (n = 95)
2010,18 Turkey
degree angle; 10 s
design; primary care
or
practice
Deltoid IM injection
(n = 90)
Physical interventions
Should skin-to-skin contact be used during vaccine injections in neonates 0-1 mo?
Hepatitis B 0.5 mL IM;
N = 640; newborn 12Mother holding diaperChermont et al
25-G needle;
72 h; between-groups
clad neonate on chest
2009 (1,2),19
Brazil
anterolateral thigh
design; single center,
(skin-to-skin) + 1 mL
hospital maternity
water 2 min before,
ward
during, and 2 min
after procedure
(n = 160)
or
Diaper-clad neonate in
crib + 1 mL water
(n = 160)
or
Mother holding diaperclad neonate on chest
(skin-to-skin) + 1 mL
dextrose 25% solution
2 min before, during,
and 2 min after
procedure (n = 160)
or
Diaper-clad neonate in
crib + 1 mL dextrose
25% solution
(n = 160)
Hepatitis B IM;
N = 36; newborns
Mother holding diaperKostandy et al
anterolateral thigh
second day of life;
clad neonate on chest
201320 (same as
between-groups
Kostandy 2005
(skin-to-skin) with
design; single center,
thesis41), USA
blanket over top for
hospital maternity
15-20 min before and
ward
6 min after injection
(n = 17)
or
Neonate clothed, supine,
with blanket over top
(n = 19)
Vaccine NR; no
N = 60; newborns after
Mother holding neonate
Saeidi et al 2011,21
Iran
injection details
ﬁrst day of life;
on chest (duration
between-groups
unclear—2 or 30 min)
design; single center,
before, during, and
hospital maternity
3 min after procedure
ward
(n = 30)
or
Neonate supine wrapped
in blanket aside
mother’s bed (n = 30)
Should holding be used (rather than lying supine) during vaccine injections in children 0-3 y?
Vaccine NR; lateral
N = 31; infants 6-26 wk;
Mother holding
Hallstrom 1968,22
USA
aspect of thigh
between-groups
infant ﬁrmly and
design; single center,
closely against

Distress: NFCS, NIPS,
PIPP

Distress: cry

Distress: NIPS

Distress: cry

(Continued )
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TABLE 2. (continued)
Author, Year,
Country

Injection Details

Population, Enrolled,
Design, Setting
university hospital
clinic

Intervention, Sample
Size*

Critical Outcomes

the body during
injection in a
position deemed
comfortable by the
mother (n = 15)

or
Infant supine (n = 16)
DPTP 0.5 mL IM; 25-G,
N = 106; infants 2Mother holding infant
Ipp et al 2004,23
Distress: NFCS, cry
Canada
16-mm needle;
6 mo; between-groups
during injection in a
anterolateral thigh
design; single center,
position deemed
primary care practice
comfortable by
mother while standing
(n = 56)
or
Infant supine (n = 50)
DPT 0.5 mL; 23-G,
N = 152; infants 2Paciﬁer 2 min before,
Taavoni et al
Distress: MBPS
2.5 cm needle
4 mo; between-groups
during, and 15 s
2010,44 Iran
(same as Taavoni
design; multicenter,
postinjection
et al 2009,46
primary care practices
(n = 38)z
27
Taavoni 2010a,
or
and Shah Ali et al
Infant supine (n = 38)
200945), Iran
or
Mother holding infant
starting 2 min before,
during, and 15 s
postinjection (n = 38)
or
Breastfeeding starting
2 min before, during,
and 15 s after injection
(n = 38)z
If holding is not used during vaccine injections, should a combined holding intervention (including patting and/or rocking) be used after
vaccine injections in children 0-3 y?
BCG or hepatitis B; no
N = 187; newborns 1Music starting 10 min
Distress: NFCS, VAS,
Chou et al 2012,24
China
injection details
2 d; between-groups
before procedure and
MAISD
design; single center,
music + nurse
hospital
cuddling in upright
position and backpatting immediately
postinjection for 3 min
(n = 88)
or
Control (infants held
transversely after
procedure and gently
patted on buttocks
and returned to crib;
caregivers able to
provide comfort)
(n = 99)
Hepatitis B, DTP-IPVN = 230; infants 2Water + control (no
Harrington et al
Distress: Modiﬁed Riley
25
Hib, PCV; 0.5 mL/
4 mo; between-groups
intervention) (n = 56)
2012 (1,2), USA
Pain Scale
vaccine IM; 23-G,
design; single center,
or
1.59-cm needle;
hospital clinic
Sucrose + control
anterolateral thigh;
(n = 58)
sequential injections
or
Water + combined
physical intervention
(swaddling, side/
stomach position,
shushing, swinging,
and sucking) (n = 58)
or
Sucrose + combined
physical intervention
(Continued )
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TABLE 2. (continued)
Author, Year,
Country

Injection Details

Population, Enrolled,
Design, Setting

Intervention, Sample
Size*

Critical Outcomes

(as described above)
(n = 58)
Should sitting upright be used (rather than lying supine) during vaccine injections in children above 3 y and adults?
MMR, DTaP, and IVP;
N = 108; children 4-6 y;
Sitting up before
Fear: Fearometer
Lacey et al 2008,26
USA
sequential injection
between-groups design;
injection (n = 52)
Pain: Wong-Baker
single center, pediatric
or
FACES Scale
clinic in a hospital
Supine position (n = 55)
Should non-nutritive sucking (eg, ﬁnger/thumb, paciﬁer) be used during vaccine injections in children 0-2 y?
Hepatitis B vaccine IM;
N = 165; newborns
Liaw et al 2011
Non-nutritive sucking
90-degree angle;
after second to third
(1),28 China
using standard
vastus lateralis;
day of life; betweensilicone newborn
aspiration before
groups design; single
paciﬁer 2 min
injection
center, nursery in a
preinjection (n = 55)
hospital
or
Control (gentle touch
and verbal comfort)
(n = 55)
or
Sucrose 20% 2 mL using
a syringe 2 min
preinjection (n = 55)z
DPT 0.5 mL; 23-G, 2.5N = 152; infants 2Paciﬁer 2 min before,
Taavoni 2010a
cm needle
4 mo; between-groups
during, and 15 s
(1),27 Iran (same
as Taavoni et al
design; multicenter,
postinjection (n = 38)
2009,46 2010,44
primary care practices
or
and Shah Ali et al
No treatment (infant
200945), Iran
supine) (n = 38)
or
Mother holding infant
starting 2 min before,
during, and 15 s
postinjection (n = 38)z
or
Breastfeeding starting
2 min before, during
and 15 s postinjection
(n = 38)z
Should manual tactile stimulation be used during vaccine injections in individuals of all ages?
Hepatitis A and
N = 74; university
Manual pressure on arm
Chung et al 2002,29
China
Hepatitis B; IM;
students; cross-over
for 10 s preinjection
alternate arms
design; single center,
by immunizer for ﬁrst
university
injection by
immunizer (n = 74)
or
Control (n = 74)
DTaP-IPV-Hib ﬁrst
Hogan et al 201430
N = 120; infants 4Rubbing skin on leg 15 s
then PCV (brand of
(same as Hogan
6 mo; between-groups
preinjection, during,
vaccine changed mid2011 thesis42),
design; single center,
and postinjection by
Canada
way through study);
primary care practice
parent (n = 60)
IM rapid injection
or
without aspiration;
Control (n = 60)
25-G, 25-mm needle;
alternate thighs
DPT; vastus lateralis
N = 60; infants 14 wk;
Tapping leg with ﬁnger
Jose et al 2012,31
India
between-groups
 2 min preinjection,
design; multicenter,
during, and up to
medical college clinics
1 min postinjection by
immunizer (n = 30)
or
Control (n = 30)
N = 693; adults above
Manual pressure on arm
Nakashima et al
32
20 y; between-groups
for 10 s preinjection by
2013, Japan

Distress: NFCS, cry

Distress: MBPS

Pain: Pain Intensity
Verbal Rating Scale

Distress: MBPS, cry,
VAS

Distress: Behavioral
Observation Pain
Scale

Pain: VAS, Faces scale
(Continued )
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TABLE 2. (continued)
Author, Year,
Country

Sparks 2001 (1)33
(same as Sparks
1998 thesis43),
USA

Injection Details
Inﬂuenza vaccine SC;
26-G, 13-mm needle;
arm
DTP (n = 22) or DTaP
(n = 83) ± oral polio
(preinjection); 0.5 mL/
vaccine IM; 22-G, 25mm needle; vastus
lateralis muscle, right,
or left leg

Population, Enrolled,
Design, Setting

Intervention, Sample
Size*

design; multicenter;
rural clinics and
general hospitals
N = 105; children 4-6 y;
between-groups
design; multicenter,
school clinics and
walk-in public health
clinic

immunizer (n = 334)
or
Control (n = 345)
Stroking skin on leg
before and during
injection with
instruction to “keep
thinking about how
nice that feels” by
immunizer (n = 33)
or
Bubble blowing
(n = 33)z
or
Control (n = 33)
Rubbing skin on leg 510 s preinjection,
during, and 5-10 s
postinjection by
immunizer (n = 62)
or
Control (n = 59)

Critical Outcomes

Pain: Oucher Scale

Hepatitis B, DPTaPN = 121; infants
Distress: MBPS, cry,
Hib, PCV, MenC, or
1-12 mo; betweenVAS
MMR; IM vaccines
groups design; single
given rapidly without
center, primary care
prior aspiration; 25practice
G, 22-mm needle;
anterolateral thigh,
left leg
Should tactile stimulation using an external vibrating device and cold be used during vaccine injections in children above 3-17 y?
DTaP, IPV, MMR; IM
N = 41; children 4-6 y;
Application of a vibrating
Berberich and
Pain: FPS-R
vaccines given ﬁrst in
between-groups
device on the
Landman 2009,35
USA
1 arm with 25-G, 5/8design; single center,
contralateral arm which
inch needle; SC
primary care practice
the child was directed to
vaccine given in other
observe as it was moved
arm with 26-G, 5/8toward the elbow;
inch needle
application of cold (ie,
vapocoolant spray—
ethyl chloride) on the
ipsilateral arm and
application of an
external (nonvibrating)
tactile stimulation
device below the
injection site (n = 20)
or
Control (n = 21)
DTaP IM; left or right
N = 104; children 7 y;
Application of a vibrating
Pain: Wong-Baker
Canbulat et al
36
deltoid
between-groups
device and cold (ie, ice
FACES Scale, VAS
2015, Turkey
design; multicenter,
pack) (Buzzy) on the
Fear: CFS
schools
ipsilateral arm about
5 cm above the site of
injection just before and
during injection
(n = 52)
or
Control (n = 52)
Should warming the vaccine before vaccine injections be used in individuals of all ages?
ADT 0.5 mL IM, no
N = 150; children and
No warming (n = 50)
Maiden et al
Pain: McGill Present
aspiration; 23-G, 25adults 16 y and above;
or
2003,37 Australia
Pain Intensity
mm needle; 60-degree
between-groups
Rubbed 1 min between
Questionnaire
angle; deltoid muscle
design; single center,
palms of hands
hospital emergency
(n = 50)
room
or
Warmed in an incubator
371C for 5 min
(n = 50)
Should muscle tension be used for vaccine injections in children 7 y and above and adults with a history of fainting?
NA “Procedure” was a
N = 23; adults 18 y and
Muscle tension
Fainting: fainting
Brignole et al
tilt-table test
above (mean age, 55 y);
(isometric handgrip
during procedure and
2002,38 Italy
history of recurrent
with contraction)
postprocedure
fainting; cross-over
(n = 19)
Taddio et al
2014a,34 Canada

(Continued )
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TABLE 2. (continued)
Author, Year,
Country

Injection Details

Population, Enrolled,
Design, Setting

Intervention, Sample
Size*

design; single center,
hospital based

or
Control (handgrip without
contraction) (n = 19)
Muscle tension (physical
counter-pressure
maneuvers: leg
crossing, arm tensing,
handgrip; held for the
longest tolerated time
or until no symptoms
of fainting with
transition to second
or third maneuver as
needed; taught
through
demonstration,
practice with
biofeedback and
provision of photos)
(n = 98)
or
Control (explanation of
mechanisms of
fainting, lifestyle
modiﬁcation tips,
pamphlet) (n = 110)
Muscle tension for
individuals with
fainting (brief
instruction and
practice with tensing
muscles 7 min)
(n = 11)
or
Muscle tension for
individuals without
fainting (brief
instruction and
practice with tensing
muscles 7 min)
(n = 11)z
or
Control for individuals
with fainting (verbal
interaction with
researcher 7 min)
(n = 11)
or
Control for individuals
without fainting
(verbal interaction
with
researcher 7 min)
(n = 11)z

van Dijk et al
2006,39 the
Netherlands

NA episodes of fainting
in everyday life

N = 223; children and
adults (16-70 y);
history of recurrent
fainting; betweengroups design;
multicenter, hospital
based

Vogele et al 2003,40
UK

NA “Procedure” was a
surgical ﬁlm

N = 44; adults
attending nonmedical
university program
(mean age, 22 y); 22
“fainters” and 22
“nonfainters”;
between-groups
design; single center,
university research
laboratory

Critical Outcomes

Fainting: 12 mo followup (using self-report
log): (1) time to
fainting recurrence;
(2) number of patients
fainting; (3) number
of episodes/patient

NA (this study was not
included in the metaanalysis for critical
outcomes)

Studies were identiﬁed using the following notation: “First Author” “Year of Publication” (eg, Taddio 2014). If studies contributed to multiple analyses,
then “(#)” was added to enable their discernment (eg, Taddio 2014 [1]). If the same author published >1 study in the same year, then a lower case letter was
added after the ﬁrst article in the same year by the same author (eg, Taddio 2014a [1]).
*Includes maximum sample size for critically important outcomes.
wData from the ﬁrst day was included in the analysis; hence the study mimicked a between-groups (parallel) design.
zData not included in the analysis.
Route: IM, intramuscular; SC, subcutaneous. Outcomes: CFS, Children Fear Scale; Cry, cry duration; FPS-R, Faces Pain Scale-Revised; MAISD,
Measure of Adult and Infant Soothing and Distress; MBPS, Modiﬁed Behavioral Pain Scale; NFCS, Neonatal Facial Coding System; NIPS, Neonatal Infant
Pain Scale; PIPP, Premature Infant Pain Scale; VAS, visual analog scale. Vaccines: ADT, adult diphtheria-tetanus; BCG, Bacille Calmette Guerin; DPTaPHib/DTP-IPV-Hib/DPTP-Hib, diphtheria, polio, tetanus, acellular pertussis, and Hemophilus inﬂuenzae type b conjugate; DPTP, diphtheria, polio, tetanus,
pertussis; DTaP, diphtheria, tetanus, acellular pertussis; DTP/DPT, diphtheria, tetanus, pertussis; DTwP, diphtheria, tetanus, whole cell pertussis; Hib,
Hemophilus inﬂuenzae type b; HPV, human papilloma virus; IVP, inactivated polio virus; min, minute; MenC, meningococcal C; MMR, measles, mumps,
rubella; mo, month; PCV, pneumococcal conjugate vaccine; s, seconds; y, year. Other: NA, not applicable; NR, not reported.
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TABLE 3. Assessment of Risk of Bias of Included Trials for Critical Outcomes

Author, Year

Blinding of
Adequate
Participants
Sequence
Allocation
Generation Concealment and Personnel

Blinding of
Outcome
Assessment

Free of Free of
Incomplete
Outcome Data Selective Other Overall
Risk
Reporting Bias
Addressed

Procedural interventions
Should no aspiration be used (rather than aspiration) during intramuscular vaccine injections in individuals of all ages?
Yes
No
No
Yes
No
Yes
Yes
Girish & Ravi 201411
Ipp et al 200710
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Unclear
No
Yes
Yes
Yes
Unclear
Petousis-Harris et al
12
2013 (1,2)
Should injecting the most painful vaccine last be used (rather than ﬁrst) during vaccine injections in individuals of all ages?
Yes
Yes
Yes
Yes
Yes
No
Yes
Ipp et al 200913
Ravikiran et al 201114
Yes
Yes
Yes
Yes
Yes
No
Yes
Should simultaneous injections be used (rather than sequential injections) during vaccine injections in infants 0-1 y?
Yes
Yes
No
Yes
Yes
Yes
Yes
Hanson et al 201015
McGowan et al 201316 Yes
Yes
No
No
Yes
Yes
Yes
Should simultaneous injections be used (rather than sequential injections) during vaccine injections in children above 1-10 y?
Yes
Unclear
No
No
Yes
Yes
No
Horn & McCarthy
199917
Should the vastus lateralis be used (rather than the deltoid) as the site of injection during vaccine injections in infants 0-11 mo?
Celebioglu et al
Unclear
Unclear
No
No
Yes
Yes
Yes
201018

High
High
High
High
High
High
High
High
High

Physical interventions
Should skin-to-skin contact be used during vaccine injections in neonates 0-1 mo?
Chermont et al 2009
Yes
Unclear
No
No
Yes
No
Yes
High
(1,2)19
Kostandy et al
Yes
Unclear
No
Unclear
Yes
Yes
Yes
High
201320
(thesis 2005)41
Saeidi et al 201121
Unclear
Unclear
No
Yes
Yes
Yes
Yes
High
Should holding be used (rather than lying supine) during vaccine injections in children 0-3 y?
22
Yes
Unclear
No
Yes
Yes
Yes
Yes
High
Hallstrom 1968
Ipp et al 200423
Unclear
Unclear
No
Yes
Yes
Yes
Yes
High
44
No
No
No
No
Yes
Yes
Yes
High
Taavoni et al 2010
(same as 2009,46
Taavoni 2010a,27 Shah
Ali et al 200945)
If holding is not used during vaccine injections, should a combined holding intervention (including patting and/or rocking) be used after vaccine
injections in children 0-3 y?
Yes
Unclear
No
No
Yes
Yes
Yes
High
Chou et al 201224
Yes
Yes
No
No
Yes
No
No
High
Harrington et al 2012
25
(1,2)
Should sitting upright be used (rather than lying supine) during vaccine injections in children above 3 y and adults?
Unclear
Unclear
No
No
Yes
Yes
Yes
High
Lacey et al 200826
Should non-nutritive sucking be used during vaccine injections in children 0-2 y?
Yes
Unclear
No
Yes
Yes
Yes
Yes
High
Liaw et al 2011 (1)28
Taavoni 2010a (1)27
No
No
No
No
Yes
Yes
Yes
High
46
(same as 2009,
2010,44 Shah Ali et al
200945)
Should manual tactile stimulation be used during vaccine injections in individuals of all ages?
Unclear
Unclear
No
No
Yes
Yes
Unclear High
Chung et al 200229
Yes
Yes
No
Yes
Yes
No
Unclear High
Hogan et al 201430
(thesis 201142)
Jose et al 201231
No
Unclear
No
No
Yes
Yes
Unclear High
No
No
No
No
Yes
Yes
Yes
High
Nakashima et al
32
2013
33
No
No
No
No
Yes
Yes
Unclear High
Sparks 2001 (1)
(thesis 199843)
Taddio 2014a34
Yes
Yes
No
Yes
Yes
Yes
Unclear High
Should tactile stimulation using an external vibrating device and cold be used during vaccine injections in children above 3-17 y?
Yes
Yes
No
No
Yes
Yes
Yes
High
Berberich and
Landman 200935
Yes
Unclear
No
No
Yes
No
Unclear High
Canbulat et al 201536
Should warming the vaccine be used before vaccine injections in individuals of all ages?
37
Yes
Yes
No
Yes
Yes
Yes
Yes
High
Maiden et al 2003
Should muscle tension be used for vaccine injections in children 7 y and above and adults with a history of fainting?
38
Unclear
Unclear
No
Unclear
Yes
Yes
Yes
High
Brignole et al 2002
van Dijk et al 200639
Unclear
Unclear
No
Yes
Yes
Yes
No
High
Unclear
Unclear
No
No
Unclear
Unclear
No
High
Vogele et al 200340
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TABLE 4. Summary of Results for Critically Important Outcomes

Critical
Outcomes*

Beneﬁt of
Interventionw

Pain, distress

Mixed

Very low

Distress

Yes

Moderate

Distress

Mixed

Low

Pain

No

Very low

Distress

Mixed

Low

Distress

Yes

Moderate

Distress

Yesy

Very low

Distress

Yes

Low

Pain, fear

Mixed

Low

Distress

Yes

Low

Pain, distress

No

Very low

Pain, fear

Mixed

Low

Pain

No

Low

Fainting

Mixed

Very low

Clinical Questions
Procedural interventions
Should no aspiration be used (rather than aspiration) during
intramuscular vaccine injections in individuals of all ages?
Should injecting the most painful vaccine last be used (rather than
ﬁrst) during vaccine injections in individuals of all ages?
Should simultaneous injections be used (rather than sequential
injections) during vaccine injections in infants 0-1 y?
Should simultaneous injections be used (rather than sequential
injections) during vaccine injections in children above 1-10 y?
Should the vastus lateralis be used (rather than the deltoid) as the
site of injection during vaccine injections in infants 0-11 mo?
Physical interventions
Should skin-to-skin contact be used during vaccine injections in
neonates 0-1 mo?
Should holding be used (rather than lying supine) during vaccine
injections in children 0-3 y?
If holding is not used during vaccine injections, should a combined
holding intervention (including patting and/or rocking) be used
after vaccine injections in children 0-3 y?
Should sitting upright be used (rather than lying supine) during
vaccine injections in children above 3 y and adults?
Should non-nutritive sucking (using a ﬁnger/thumb, paciﬁer) be
used during vaccine injections in children 0-2 y?
Should manual tactile stimulation be used during vaccine injections
in individuals of all ages?
Should tactile stimulation using an external vibrating device and
cold be used during vaccine injections in children above 3-17 y?
Should warming the vaccine before vaccine injections be used in
individuals of all ages?
Should muscle tension be used for vaccine injections in children 7 y
and above and adults with a history of fainting?

Quality of Evidencez

*Includes results for the critical outcomes that were evaluated in included studies only.
wThe results for the eﬀect of the intervention have been summarized across all evaluated critical outcomes, and are expressed using the following notation:
Yes, beneﬁt was observed across all evaluated critical outcomes; Mixed, beneﬁt was observed for 1 or more but not all evaluated critical outcomes; No, no
evidence of beneﬁt was observed for any of the evaluated critical outcomes.
zReﬂects the lowest quality of evidence rating across all evaluated critical outcomes, whereby rankings range from high to moderate to low to very low.
yOn the basis of the results after removal of 1 study with a high risk of bias; see text for details.

links.lww.com/CJP/A283 and Figure http://links.lww.com/
CJP/A297, SDC 2).

Should Simultaneous Injections be Used (Rather Than
Sequential Injections) During Vaccine Injection in
Infants 0 to 1 Year?
Two studies including infants aged 2 to 6 months were
included.15,16 The quality of evidence for the critical outcome of distress was low and the results were mixed for
diﬀerent indicators of distress (see Table http://links.lww.
com/CJP/A284 and Figure, http://links.lww.com/CJP/
A298 SDC 3). In the only analysis that included data from
both studies (n = 172), there was evidence for a reduction
in acute distress in the simultaneous injection group: SMD
0.56 (95% CI: 0.87,  0.25). Either a beneﬁt or no
diﬀerence was observed for other indicators of distress.

Should Simultaneous Injections be Used (Rather Than
Sequential Injections) During Vaccine Injection in
Children Above 1 to 10 Years?

In 1 study including children aged 4 to 6 years,17 there
was no evidence of a beneﬁt for pain from simultaneous
injections (n = 44): SMD 0.31 (95% CI: 0.29, 0.90) (see
Table http://links.lww.com/CJP/A285 and Figure, http://

Copyright
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links.lww.com/CJP/A299 SDC 4). There was very low
quality of evidence for this outcome (see Table, http://
links.lww.com/CJP/A285 SDC 4).

Should the Vastus Lateralis be Used (Rather Than the
Deltoid) as the Site of Injection During Vaccine
Injections in Infants 0 to 11 Months?
One trial including 185 infants aged 4 months compared vaccine injections in the vastus lateralis versus the
deltoid muscle.18 The quality of the evidence was low and the
results were mixed (see Table http://links.lww.com/CJP/
A286 and Figure, http://links.lww.com/CJP/A300 SDC 5).
Less distress was observed for the vastus lateralis site during
the acute and recovery procedure phases combined: SMD
0.70 (95% CI: 1.00, 0.41); however, there was no
diﬀerence between groups during the acute procedure phase:
SMD 0.11 (95% CI: 0.18, 0.40).

Should Skin-to-Skin Contact be Used During Vaccine
Injections in Neonates 0 to 1 Month?
Three randomized trials in 736 neonates investigated
skin-to-skin contact (whereby diaper-clad infants are positioned between their mother’s breasts) versus lying
supine.19–21 Skin-to-skin contact was initiated at least
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2 minutes before vaccine injection(s). The quality of evidence was moderate and there was evidence of beneﬁt of
this intervention across diﬀerent phases of the procedure
(see Table http://links.lww.com/CJP/A287 and Figure,
http://links.lww.com/CJP/A301 SDC 6). For acute procedural distress speciﬁcally, the SMD was 0.65 (95% CI:
1.05,  0.25). For the recovery procedure phase, the
SMD was 0.89 (95% CI: 1.26, 0.52).

Should Holding be Used (Rather Than Lying Supine)
During Vaccine Injections in Children 0 to 3 Years?
Three trials examined holding versus lying supine
during injections in infants aged 6 weeks to 6 months.22,23,44
Holding was carried out by a parent and was initiated
before vaccine injection(s) and continued during and after
injection(s). There was low to very low quality evidence
across the diﬀerent outcomes of distress (see Table, http://
links.lww.com/CJP/A288 SDC 7). No signiﬁcant beneﬁt of
holding was observed (n = 213): SMD  0.72 (95% CI:
1.95, 0.51); however, in 1 included study, there was
contamination of the control (lying supine) group whereby
parents picked up infants immediately after vaccinations.23
Removal of the data from this study altered the results for
acute distress; infants in the holding group had lower levels
of distress compared with infants in the supine group: SMD
1.25 (95% CI: 2.05, 0.46). The results were not signiﬁcant for other distress outcomes; although data were
obtained by the same methodologically diverse study (see
Table http://links.lww.com/CJP/A288 and Figure, http://
links.lww.com/CJP/A302 SDC 7).

If Holding is Not Used During Vaccine Injections,
Should a Combined Holding Intervention (Including
Patting and/or Rocking) be Used After Vaccine
Injections in Children 0 to 3 Years?
Two studies in infants aged 1 day to 4 months examined holding interventions after injections in infants lying
supine during vaccination.24,25 The holding interventions
included cuddling and back-patting24 or swaddling, sidelying, swinging, shushing, and sucking25 by a clinician. The
way parents usually comfort their infants after vaccination
was the comparison condition. There was low quality evidence and a beneﬁt of the holding intervention was
observed for both measures of distress evaluated: acute
procedure distress and acute and recovery procedure distress combined (see Table http://links.lww.com/CJP/A289
and Figure, http://links.lww.com/CJP/A303 SDC 8). In the
analysis including data from both studies (ie, distress during
the acute and recovery phases) (n = 417 infants), the SMD
was  0.65 (95% CI:  1.08, 0.22).

Should Sitting Upright be Used (Rather Than Lying
Supine) During Vaccine Injections in Children Above 3
Years and Adults?
In 1 trial including children aged 4 to 6 years, sitting
upright was compared with lying supine.26 Pain and fear
were critically important outcomes, and for both, the
quality of evidence was low (see Table, http://links.lww.
com/CJP/A290 SDC 9). The results were mixed: children in
the sitting upright group reported lower levels of fear than
those lying supine group postintervention (ie, after positioning but before the procedure) (n = 107): SMD 0.39
(95% CI:  0.77, 0.01); pain from vaccination, however,
did not diﬀer signiﬁcantly between groups: SMD 0.07 (95%
CI:  0.31, 0.45). Given the young age range of the children
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that participated and the possibility of diﬃculty with selfreport in this age group, we also examined distress. There
was a signiﬁcant reduction in acute and recovery period
distress combined in the intervention group: SMD 10.3
(95% CI: 20.18, 0.42) (see Table http://links.lww.com/
CJP/A290 and Figure, http://links.lww.com/CJP/A304
SDC 9).

Should Non-nutritive Sucking (eg, Finger/Thumb,
Paciﬁer) be Used During Vaccine Injections in
Children 0 to 2 Years?
Two studies including infants from 0 to 4 months of
age were included in the systematic review.27,28 There was
low quality evidence across the diﬀerent outcomes of distress that were evaluated and evidence of beneﬁt for all of
them (see Table http://links.lww.com/CJP/A291 and Figure, http://links.lww.com/CJP/A305 SDC 10). In the only
analysis including both studies (n = 186 infants), the SMD
was 1.88 (95% CI:  2.57, 1.18) for the outcome of
acute distress. The rate of sucking may be important for
eﬀectiveness; included studies did not determine sucking
rate.

Should Manual Tactile Stimulation be Used During
Vaccine Injections in Individuals of All Ages?
Altogether, 6 studies investigated the eﬀects of manual
tactile stimulation versus no treatment on vaccine injection
pain in infants, children, and adults.29–34 The intervention
was delivered in various ways, including; manual pressure,
rubbing/stroking, and tapping. The clinician delivered the
intervention in all but 1 study, which used a parent
instead.30 There was moderate to very low quality evidence
for critical outcomes (pain and distress) (see Table, http://
links.lww.com/CJP/A292 SDC 11). For 3 studies including
an evaluation of self-reported pain (n = 893),29,32,33 there
was insuﬃcient evidence of a beneﬁt of manual tactile
stimulation: SMD 0.38 (95% CI: 0.96, 0.21). In the
remaining 3 studies in infants,30,31,34 there was no evidence
of a beneﬁt across indicators of distress, even when the
study including parents as the deliverers of the intervention30 was excluded. In the only analysis that included
all studies (n = 301 infants), the SMD was 0.69 (95% CI:
1.77, 0.39) for acute distress (see Table http://links.lww.
com/CJP/A292 and Figure, http://links.lww.com/CJP/
A306 SDC 11). The evidence base included heterogeneity in
the delivery of the intervention, type of injection, and
cointerventions.

Should Tactile Stimulation Using an External
Vibrating Device and Cold be Used During Vaccine
Injection in Children Above 3 to 17 Years?
Two studies including children aged 4 to 7 years investigated the eﬀect of externally applied vibrating devices with
cold.35,36 In 1 study, a multifaceted tactile intervention was
used whereby a vibrating device was applied to the contralateral arm in the form of a game, and an external tactile
device was pressed on the skin on the ipsilateral side. In
addition, a vapocoolant was sprayed on the vaccination site
immediately before injection with a verbal suggestion of
diminished sensation.35 In the other study, a vibrating device
decorated as a bee with an ice pack attached to the underside
(Buzzy) was applied by a researcher on the arm being vaccinated just above the injection site and kept there until the
end of the injection.36 The quality of evidence for the critical
outcomes (pain, fear) was low (see Table 12, http://
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links.lww.com/CJP/A293 SDC 12). There was a beneﬁt of the
vibrating device plus cold on pain (n = 145): SMD 1.23
(95% CI: 1.58, 0.87). There was no evidence of a beneﬁt
for fear (n = 104): SMD 0.28 (95% CI: 0.11, 0.66) (see
Table http://links.lww.com/CJP/A293 and Figure, http://
links.lww.com/CJP/A307 SDC 12). The contribution of cold
and distraction to the eﬀectiveness of both of these tactile
interventions is not known.

Should Warming the Vaccine Before Vaccine
Injections be Used in Individuals of All Ages?
One study evaluated the eﬀect of warming the vaccine
on vaccine injection pain in 150 adults.37 Vaccines warmed
by rubbing with hands or by inserting into an incubator
immediately before injection were compared with no
warming. Because of similarities in the temperature of the
vaccine achieved with both warming techniques (27 and
291C, respectively), the data were combined and compared
with the no warming group (191C). There was low quality
evidence for the critical outcome of pain and pain did not
diﬀer between those that received the warmed vaccine versus
those that received unwarmed vaccine: SMD 0.02 (95% CI:
0.32, 0.36) (see Table http://links.lww.com/CJP/A294 and
Figure, http://links.lww.com/CJP/A308 SDC 13).

Should Muscle Tension be Used for Vaccine Injections
in Children 7 Years and Above and Adults With a
History of Fainting?
Three studies including individuals in mid to late
adolescence through adulthood were included; none of the
studies evaluated the vaccination context.38,39,40 Muscle
tension was achieved using a variety of physical maneuvers
and both cyclical (muscle tension then release and repeat)
and holding (continuous tension) methods were used. Some
training was provided (eg, demonstration, instruction,
practice with biofeedback, photos of maneuvers, supervision, and feedback). The critical outcome was fainting.
Two of the studies were included in the meta-analysis38,39
and fainting was assessed in these studies using a tilt-table
test or year-long follow-up of everyday life. The results were
mixed for diﬀerent indicators of fainting and the quality of
evidence was very low (see Table http://links.lww.com/CJP/
A295 and Figure, http://links.lww.com/CJP/A309 SDC 14).
Muscle tension resulted in beneﬁts in the number of individuals fainting acutely during a procedure (n = 38; RR:
0.11 [0.02, 0.79]), number of individuals fainting over a 1year period (n = 208; RR: 0.62 [0.44, 0.88]), and number of
fainting episodes/individual/year (n = 208; SMD: 3.32
[95% CI: 3.74,  2.90]). It did not demonstrate a beneﬁt
on postprocedural fainting (although the tension had ceased
at that time), or time to recurrence at follow-up.

DISCUSSION
This systematic review was undertaken to determine the
eﬀectiveness of diﬀerent procedural and physical interventions
that can be used by immunizers to reduce pain, fear, distress,
fainting related to vaccine injections, or more than one. There
was some evidence to support the following interventions in
select populations: no aspiration during IM injections, injecting the most painful vaccine last when multiple vaccines are
injected, simultaneous injections rather than sequential injections, IM injection into the vastus lateralis rather than the
deltoid, positioning interventions (skin-to-skin contact, holding, or upright positioning rather than lying supine), nonCopyright

r

Physical And Procedural Vaccination Pain Strategies

nutritive sucking, tactile stimulation using an external vibrating device and cold, and muscle tension. There was insuﬃcient
evidence to support warming the vaccine before injection and
manual tactile stimulation.
The results were mixed regarding the impact of no
aspiration for IM vaccine injections. In 1 study including
adolescents and adults,12 there was no evidence of a beneﬁt of
avoiding aspiration on self-reported pain, whereas in the
other studies including infants,10,11 there was a beneﬁt on
measures of infant distress. The discrepant results in the
former study may be explained by diﬀerences in study design
and execution, including: use of a particularly painful vaccine,54 insuﬃcient time for aspiration, and variability in
anatomic site of injection. As aspiration is not a necessary
step of IM vaccine injections55 and incurs additional needle
dwelling time to ensure it is undertaken appropriately with
the potential for wiggling of the needle within the tissue,
additional tissue damage and pain, there is no rationale for
performing it. It is unclear whether the results in the latter
studies were confounded by diﬀerences in injection speed as
the no aspiration technique was coupled with a fast injection
(vs. aspiration with slow injection). The speciﬁc impact of
injection speed requires further study.
This review found that injecting the most painful
vaccine last when 2 vaccines are administered sequentially
results in less pain. The ﬁndings are consistent with animal
and human studies demonstrating a relationship between
future pain and previous pain, and increasing pain after
repeated noxious sensory stimulation.56–60 These results,
however, are limited to the combinations of vaccines that
were evaluated in included studies. Additional studies are
needed to determine the relative “painfulness” of other
vaccines that are routinely given in combination to provide
more complete guidance to immunizers with respect to the
order of their administration to minimize pain.
Another intervention with some evidence of a beneﬁt in
the context of multiple separate vaccine injections is simultaneous injections. Simultaneous injections were demonstrated
to reduce infant distress. However, there was no observable
beneﬁt in children. It is possible that children become fearful
when approached by 2 immunizers and that this counteracts
any beneﬁt of the intervention in this age group. It is important
to note that infants begin to develop “stranger anxiety” in the
presence of unknown adults that may be exacerbated in the
presence of a greater number of unknown adults needed to
deliver this intervention, which could increase distress; in such
cases, alternatives to this intervention should be considered.
Stranger anxiety is developmentally normal and tends to be
present in infants above 6 months.61 Additional resources (ie,
multiple immunizers) are also required to deliver this intervention making feasibility an issue.
The vastus lateralis is a muscle situated on the outer
aspect of the upper thigh and is currently recommended as
the primary site of vaccination for infants.55 One study
compared infant distress from vaccine injection in the vastus
lateralis versus the deltoid,18 a muscle in the upper arm—the
preferred vaccination site in older children and adults.55
There was some evidence of beneﬁt on infant distress, providing support for the vastus lateralis as the primary site for
vaccination of infants. There were no other studies that
compared the eﬀects of alternative anatomic sites of injection
on pain. There are, however, observational studies reporting
on preferences or actual uptake of vaccines according to the
route of administration. In these studies, the intranasal route
was preferred over the IM route.62–64
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There was clear evidence of a beneﬁt of skin-to-skin contact for reducing vaccine injection pain in neonates. These
results are consistent with a recent meta-analysis of skin-to-skin
contact for procedural pain in neonates.65 The eﬀectiveness of
this intervention when applied by individuals other than the
mother (eg, father) in the context of vaccination, however, is not
known. In limited data in hospitalized neonates undergoing
other needle procedures, there was no evidence of a diﬀerence
when this intervention was delivered by a diﬀerent individual,
including the father or an alternate female.65
There was some evidence of a beneﬁt of holding during
vaccine injections in infants after removal of the data from 1
study from the meta-analysis that included contamination of
the control group.23 The optimal holding position, however,
is not known and may depend on infant preferences; holding
in a parent’s lap in a gentle hug with the child’s legs on either
side of the parent may be one way to deliver this intervention
that results in child comfort and keeps limbs still without
leading to undue restraint (that can further increase distress).66 A combined holding intervention administered after
injection was also demonstrated to reduce infant distress. The
intervention consisted of cuddling and back-patting24 or
swaddling, side-lying, swinging, sucking, and shushing.25 In
included studies, however, the holding intervention was
delivered by a clinician and parents would have to be trained
to deliver the intervention to make it a feasible intervention
across clinical settings. Of note, close proximity soothing is
regarded as a developmental need for infants in distress.67
There was a beneﬁt of sitting upright on children’s selfreported fear in 1 study included in the systematic review.26 It
has been hypothesized that individuals are less afraid when
sitting up than lying down and sitting up has been recommended for children as soon as they can maintain head and
trunk control.66,68 As with infants, methods of positioning that
eﬀectively comfort and secure limbs without undue force are
recommended for children. This may include sitting on a
parent’s lap. Of note, in included studies, parents also preferred
to have their children sitting up for injections and there was no
evidence of an increase in the duration of the procedure.26
Non-nutritive sucking was demonstrated to reduce infant
distress during vaccination. This is consistent with the ﬁndings
of a separate systematic review of procedural pain management in neonates including non-nutritive sucking.69 The
mechanism underlying the eﬀectiveness of non-nutritive sucking is not known, but may involve blocking the perception of
pain, distraction, or both.70 The rate of sucking may be
important for eﬀectiveness; included studies, however, did not
determine the sucking rate. This intervention is suitable for
infants that regularly use paciﬁers. An adult may also be
required to gently hold the device in place to stimulate sucking
and to prevent it from falling out of the child’s mouth. It is
important to note that some infants may refuse to suck and
should not be forced to do so as it may increase distress.
There was no evidence of a beneﬁt of manual tactile
stimulation. The proposed mechanism of tactile stimulation
as a pain treatment involves the gate control theory of pain
and the notion that the touch sensation competes with the
pain sensation to reduce the pain signal to the brain.71 There
are several possible reasons for the lack of observed eﬀect of
manual tactile stimulation, including: (1) discomfort induced
by the intervention due to excessive pressure, other aversive
aspects of intervention delivery, or both; (2) fear induced by
proximity of the immunizer and increased attention to the
vaccination procedure by the individual; and (3) cointervention due to tactile stimulation being applied when
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holding infants and children or when securing limbs before
vaccine administration, concurrent tactile stimulation applied
during actual vaccine delivery (eg, pinching or pressing on the
skin), or both. Together, these factors may have obscured or
reduced any observable beneﬁt of this intervention.
There was, however, a beneﬁt observed for tactile stimulation when delivered to children undergoing vaccine injections
using an external vibrating device coupled with cold. It is likely
that the eﬀectiveness of this intervention involves more than 1
mechanism. Distraction, cold, and suggestion may all have
played a role in the eﬀectiveness of this intervention. Separately,
signiﬁcant beneﬁt of the intervention has been observed in
children up to 18 years undergoing venipuncture.72,73 Limitations for the use of this intervention includes the need for
additional resources to deliver them, including supplies
(vibrating devices) and personnel (to administer it). One recent
study trained parents to administer the intervention to avoid the
need for additional personnel.74 Finally, consideration should
be given to the cold sensation produced with this intervention
(ie, vapocoolant spray or Buzzy) as it may lead to discomfort in
some individuals.2,75,76 It is possible to deliver the tactile component of both interventions without the cold component
although the eﬀectiveness of this is not known.
Warming the vaccine was not demonstrated to impact
pain. The proposed mechanism for this intervention is that
cold solutions stimulate nociceptors.77 It is possible that the
temperature achieved in the warming group, which was
<301C, was not suﬃciently close to the body temperature
to prevent pain. In a previous meta-analysis of warming
local anesthetic solutions before injection, a signiﬁcant
reduction was demonstrated when body temperature
(Z371C) was attained during warming of the solution.77 In
contrast, it is possible that the temperature achieved in the
control group, which was approximately room temperature, may have been suﬃciently high compared with usual
refrigerated vaccine temperatures that it approximated an
active treatment and was not suﬃciently cooler than the
warmed vaccine for warming to have demonstrated a beneﬁt. Because of the lack of observed beneﬁt of warming
from the included trial, warming of vaccines is not recommended. It is important to additionally note that correct
storage and handling temperatures are of paramount
importance in maintaining biological activity of vaccines
and that warming may impact vaccine eﬀectiveness.
Pain and seeing blood, needle procedures, or both are
included in the top 5 triggers for fainting.78 Muscle tension
combats the vasovagal response that otherwise leads to
fainting by increasing blood pressure and cerebral blood
ﬂow. In this intervention, individuals learn to tense muscles
of the body and can also learn the signs of a drop in blood
pressure (ie, prodromal vasovagal signs) so that the tension
technique can be utilized to prevent the onset of symptoms,
or both arrest them once they appear. There was evidence
for the eﬀectiveness of muscle tension with respect to
fainting both acutely during a procedure and number of
fainting episodes per patient per year. Although the evidence base did not include vaccine injections speciﬁcally,
there is no reason to believe that results would be diﬀerent
in this context; muscle tension has also reduced fainting
responses in volunteer blood donors.79 The use of muscle
tension in vaccination contexts should be addressed in
future research, including training of individuals on the
spot. Caution is recommended with respect to positioning
during vaccine injections to avoid falls; supported or a
reclined sitting position are possible options.
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A major limitation of the ﬁndings from this knowledge
synthesis is the scant evidence base that exists for most of
the evaluated interventions. Considering the vast number of
vaccine injections that are performed worldwide and the fact
that they occur in individuals of all ages, it is surprising that
such little empiric evaluation of physical and procedural
interventions has been undertaken. There is the possibility
that some trials may have been missed, however, this risk
was reduced by having a broad search strategy including
gray literature (theses), articles published in other languages,
and involving 2 reviewers in screening citation lists.3 The
risk of bias was high for all included trials, leading to
uncertainty in the internal validity of the ﬁndings. In most
cases it was diﬃcult to blind personnel, such as immunizers,
to the intervention. In addition, included studies often
evaluated individuals of limited age ranges, and it is unclear
that the results can be extrapolated to other ages. Strengths
of the analysis, however, include the rigorous approach that
included both GRADE and Cochrane methodologies, and a
comprehensive approach to data synthesis that utilized the
results of multiple outcome measures assessing the same
construct within studies and combined data across studies.
A priori, the eﬀectiveness of speciﬁc interventions was
analyzed separately to account for diﬀerences in intervention characteristics (eg, delivery) and developmental
stage. This allowed for more ﬁne-grained examination of
intervention eﬀectiveness. Other aspects of the methodological approach used in this systematic review are
reviewed separately in another manuscript in this series.80
In conclusion, there are a variety of procedural and
physical interventions that clinicians can use to improve the
quality of pain care in individuals undergoing vaccine injections. Implementation of these interventions is contingent on
the ability and willingness of vaccinators to use them. To this
end, government agencies and educational institutions are
encouraged to develop policies and resources that facilitate
uptake of these interventions across practice settings. In
addition, additional research is recommended to expand and
strengthen the evidence base. New technologies are also warranted, including: adjustment of physicochemical characteristics of new vaccines to be less painful, combination vaccines,
microneedles, and needle-free vaccine approaches (such as
oral, transdermal, mucosal, and inhalational).
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